IRay Technology Company Limited
688301
Hisse Senetlerindeki Sıralama
#4523
iRay Technology Company Limited specializes in the development, manufacturing,... iRay Technology Company Limited specializes in the development, manufacturing, and global distribution of sophisticated flat panel X-ray detectors. These critical imaging components are utilized across a broad spectrum of applications, including medical diagnostics, dental imaging, oncology treatment planning, veterinary care, security screening, and industrial inspection, serving markets both within China and internationally. The company's diverse product portfolio features solutions such as wireless and tethered radiography panels, mammography detectors, dynamic/real-time imaging systems, and linear detector arrays, all supported by essential accompanying software. Founded in 2011, iRay Technology is headquartered in Shanghai, China.
Hisse Fiyatı
$10.68
Piyasa Değeri
$3.34B
Değişim (1 gün)
-5.37%
Değişim (1 yıl)
-6.06%
Ülke
CN
Ticaret IRay Technology Company Limited (688301)
Kategori
Healthcare
IRay Technology Company Limited (688301) için kazanç
2026 itibarıyla kazanç TTM: 0
IRay Technology Company Limited şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
IRay Technology Company Limited için kazanç geçmişi 2015 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2025 | $98.00M | 41.01% |
| 2024 | $69.50M | -28.18% |
| 2023 | $96.77M | -5.81% |
| 2022 | $102.74M | 16.62% |
| 2021 | $88.10M | 126.31% |
| 2020 | $38.93M | 163.25% |
| 2019 | $14.79M | 50.90% |
| 2018 | $9.80M | -1.55% |
| 2017 | $9.95M | 40.00% |
| 2016 | $7.11M | 94.34% |
| 2015 | $3.66M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $3.62B | - |
US
|
|
| $4.11B | - |
FR
|
|
| - | - |
JP
|
|
| $1.59B | - |
US
|
|
| - | - |
CH
|
